Sun Pharmaceuticals Expects revenue growth of 13-15% on consolidated basis
Highlights of the call Net sales for the quarter ended March’09 on consolidated basis declined by 10% to Rs 1134.41 crore and Net profit declined by 45% to Rs 394.88 crore. For the year ended March’09, net sales posted moderate growth of 27% to Rs 4272.30 crore and net profit rose by 22% to Rs … Read more Sun Pharmaceuticals Expects revenue growth of 13-15% on consolidated basis